This Solicitation opportunity from Department Of Defense was posted on May 31, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
ATENOLOL TABLETS, US
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
This contract is for the procurement of Atenolol Tablets, 25 mg, packaged in bottles of 100 tablets each. The item is identified by the National Stock Number 6505-01-336-6196, with a unit of issue of one bottle per contract line item and requires delivery within 20 days to the destination specified, Fort Bragg. The tablets have a non-extendable shelf life of 36 months and must comply with strict packaging and marking standards, including adherence to Medical Marking Standard No. 1 to ensure product integrity and proper identification during shipping and receipt. The contract incorporates technical and quality requirements as outlined in the Defense Logistics Agency’s (DLA) master list, which controls the applicable standards based on solicitation or award dates. Packaging must be commercial grade, providing protection from damage and breakage, and shipped in appropriate containers meeting export regulations when applicable. Inspection and acceptance will occur at the destination, and all markings must comply with specifications related to covered defense information. The contract involves recognized manufacturers such as McKesson Corporation, Mylan Pharmaceuticals, and Teva Pharmaceuticals and follows federal procurement regulations under NAICS code 325412 for pharmaceutical manufacturing. Communication and clarifications are handled by a designated point of contact from the Medical Supply Chain Pharmacy FSA at the Department of Defense.
General Info
Agency
NAICS
Place of Performance
2530 TAYLOR STREET BLDG NUMBER 2530, FORT BRAGG, NC, 28310, USSet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
ATENOLOL TABLETS,25 MG,100S
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. 1 BT = 100 TT RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
SHALL BE MARKED IAW THE LATEST EDITION OF
SPE2DP-26-T-3590
SECTION B
THE MEDICAL MARKING STANDARD NO. 1.
MMS NO. 1 IS AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
MCKESSON CORPORATION 34WR5 P/N 463649 MYLAN PHARMACEUTICALS INC 3KJG9 P/N NDC00378-0218-01 TEVA PHARMACEUTICALS USA, INC. 3V8D7 P/N NDC00093-0787-01
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016959368 0001 BT 1.000
NSN/MATERIAL:6505013366196
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-336-6196 Quantity: 1 BT Purchase Request: 7016959368QTY: 1 Delivery: 20 days ADO
